Experienced in Polymyalgia Rheumatica

Sjoukje F. Oosting

Department Of Otorhinolaryngology/Head And Neck Surgery, 
Groningen, GR, NL 
Experienced in Polymyalgia Rheumatica
Department Of Otorhinolaryngology/Head And Neck Surgery, 
Groningen, GR, NL 
OverviewLocationsClinical Research

Overview

Sjoukje Oosting practices in Groningen, Netherlands. Oosting is rated as an Experienced expert by MediFind in the treatment of Polymyalgia Rheumatica. Their top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Testicular Cancer, Renal Cell Carcinoma (RCC), Orchiectomy, and Laryngectomy.

Their clinical research consists of co-authoring 110 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Polymyalgia Rheumatica.

Locations

Department Of Otorhinolaryngology/Head And Neck Surgery, Groningen, GR, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment Status: Terminated
Publish Date: July 10, 2024
Intervention Type: Drug
Study Drugs: Feladilimab, Pembrolizumab
Study Phase: Phase 3
Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
Comparison of Concomitant Cisplatin Versus Carboplatin and 5-fluorouracil With Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
Enrollment Status: Completed
Publish Date: May 06, 2024
Intervention Type: Drug
Vaccination Against cOvid In CancEr
Vaccination Against cOvid In CancEr
Enrollment Status: Active_not_recruiting
Publish Date: May 03, 2024
Intervention Type: Biological
Study Drug: Moderna mRNA-1273 COVID-19 Vaccine
Study Phase: Not Applicable
View 2 Less Clinical Trials

110 Total Publications

Genomic distinctions in adolescent and young adult cancer: A comprehensive review.
Genomic distinctions in adolescent and young adult cancer: A comprehensive review.
Journal: Cancer treatment reviews
Published: July 24, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Oosting's expertise for a condition
ConditionClose
    View All 25 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile